Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse modelRulaiha Taylor, Grace L. Guo, Vik Meadows et al.|Toxicological Sciences|2024Cited by 6
Deletion of hepatic FXR leads to more severe MASH development in female mice.Zakiyah Henry, Grace L. Guo, Laura E. Armstrong et al.|PubMed|2025Cited by 2
Mutation of PXR phosphorylation motif at Ser347 disrupts lipid and bile acid homeostasis in diet-induced metabolic dysfunction–associated steatohepatitis in miceVeronia Basaly, Grace L. Guo, Rulaiha Taylor et al.|Drug Metabolism and Disposition|2025Cited by 0